Carriers of biallelic SLC34A1 variants had often hypophosphatemia, hyperphosphaturia (or decreased TmP/GFR or TRP), elevated calcitriol, and hypercalciuria with failure to thrive, bone manifestations, and nephrocalcinosis/-lithiasis. The gene discussed is SLC34A1; the disease is nephrocalcinosis.